Effects of Dexamethasone in Primary Supratentorial Intracerebral Hemorrhage

New England Journal of Medicine

Volumn 316, Issue 20, 1987, Pages 1229-1233

  Poungvarin, Niphon ^a,b,c   Bhoopat, Wiyada ^a,b,c   Viriyavejakul, Adulya ^a,b,c   Rodprasert, Prakit ^a,b,c   Buranasiri, Panya ^a,b,c   Sukondhabhant, Sombut ^a,b,c   Hensley, Michael J ^a,b,c   Strom, Brian L ^a,b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PLACEBO;

BRAIN HEMORRHAGE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; DRUG INDICATION; DRUG THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THERAPY;

EID: 0023175662     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198705143162001     Document Type: Article

References (38)

1. Fishman RA. The pathophysiology and treatment of brain edema. In: Matthews WB. Glaser GH, eds. Recent advances in clinical neurology. Vol. 2. Edinburgh: Churchill Livingstone, 1978:119–27.
2. Maxwell RE, Long DM, French LA. The clinical effects of a synthetic gluco-corticoid used for brain edema in the practice of neurosurgery. In: Reulen HJ, Schürmann K. eds. Steroids and brain edema. Berlin: SpringerVerlag, 1972:219–32.
3. Russek HI. Russek AS, Zohman BL. Cortisone in immediate therapy of apoplectic stroke. JAMA 1955; 159: 102–5.
4. Patten BM, Mendell J. Bruun B. Curtin W, Carter S. Double-blind study of the effects of dexamethasone on acute stroke. Neurology 1972; 22: 377–83.
5. Bauer RB. Tellez H. Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction. Stroke 1973; 4: 547–55.
6. Norris JW. Steroid therapy in acute cerebral infarction. Arch Neurol 1976; 33: 69–71.
7. Dyken M, White PT. Evaluation of cortisone in the treatment of cerebral infarction. JAMA 1956; 162: 1531–4.
8. Mulley G, Wilcox RG, Mitchell JRA. Dexamethasone in acute stroke. Br Med J 1978; 2: 994–6.
9. Norris JW, Hachinski VC. High dose steroid treatment in cerebral infarction. Br Med J 1986; 292: 21–3.
10. Tellez H, Bauer RB. Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke 1973; 4: 541–6.
11. Walton JN. Brain's diseases of the nervous system. 9th ed. London: Oxford University Press, 1985:214–8.
12. Adams RD, Victor M. Principles of neurology. 3rd ed. New York: McGraw-Hill. 1985:612–6.
13. Sahs AL. Hartman EC, Aronson SM. Stroke: cause, prevention, treatment, and rehabilitation. London: Castle House Publications. 1979:120–32.
14. Marshall J. The management of cerebrovascular disease. 3rd ed. Oxford: Blackwell, 1976:87–99.
15. Richardson A. Spontaneous intracerebral and cerebellar hemorrhage. In: Ross Russell RW, ed. Cerebral arterial disease. Edinburgh: Churchill Livingstone. 1976:210–30.
16. Toole JF, Patel AN. Cerebrovascular disorders. New York: McGraw-Hill. 1967:246–54.
17. Teasdale G. Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; 2: 81–4.
18. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64: 191–9.
19. Armitage P. McPherson CK, Rowe BC. Repeated significance tests on accumulating data. J R Stat Soc 1969; 132: 235–44.
20. McPherson K. Statistics: the problem of examining accumulating data more than once. N Engl J Med 1974; 290: 501–2.
21. Marquardsen J. Natural history and prognosis of cerebrovascular disease. In: Ross Russell RW. ed. Cerebral arterial disease. Edinburgh: Churchill Livingstone. 1976:24–39.
22. Hutchinson EC, Acheson EJ. Strokes: Natural history, pathology and surgical treatment. London: W.B. Saunders, 1975:138–53.
23. Office of Biometry and Field Studies. National Institute of Neurological and Communicative Disorders and Stroke. National survey of stroke. Bethesda. Md.: National Institutes of Health 1983.
24. Jennett B. Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet 1975; 1: 480–4.
25. Young MJ, Bresnitz EA, Strom BL. Sample size nomograms for interpreting negative clinical studies. Ann Intern Med 1983; 99: 248–51.
26. Detsky AS. Sackett DL. When was a “negative” clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med 1985; 145: 709–12.
27. Withrow CD, Woodbury DM. Some aspects of the pharmacology of adrenal steroids and the central nervous system. In: Reulen HJ, Schürmann K, eds. Steroids and brain edema. Berlin: Springer-Verlag, 1972:41–55.
28. Nelson SR, Dick AR. Steroids in the treatment of brain edema. In: Azarnoff DL, ed. Steroid therapy. Philadelphia: W.B. Saunders. 1975:313–24.
29. Gudeman SK, Miller JD. Becker DP. Failure of high-dose steroid therapy to influence intracranial pressure in patients with severe head injury. J Neurosurg 1979; 51: 301–6.
30. Cooper PR, Moody S, Clark WK, et al. Dexamethasone and severe head injury: a prospective double-blind study. J Neurosurg 1979; 51: 307–16.
31. Saul TG, Ducker TB, Salcrnan M, Carro E. Steroids in severe head injury: a prospective randomized clinical trial. J Neurosurg 1981; 54: 596–600.
32. Warrell DA, Looareesuwan S, Warrell MJ, et al. Dexamethasone proves deleterious in cerebral malaria: a double-blind trial in 100 comatose patients. N Engl J Med 1982; 306: 313–9.
33. Reulen HJ, Hadjidimos A, Schürmann K. The effect of dexamethasone on water and electrolyte content and on rCBF in perifocal brain edema in man. In: Reulen HJ, Schürmann K, eds. Steroids and brain edema. Berlin: Springer-Verlag, 1972:239–52.
34. Beks JWF, Doorenbos H, Walstra GJM. Clinical experiences with steroids in neurosurgical patients. In: Reulen HJ, Schürmann K, eds. Steroids and brain edema. Berlin: Springer-Verlag, 1972:233–8.
35. Siemkowicz E. Hyperglycemia in the reperfusion period hampers recovery from cerebral ischemia. Acta Neurol Scand 1981; 64: 207–16.
36. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983; 74: 540–4.
37. Candelise L, Landi G, Orazio EN, Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol 1985; 42: 661–3.
38. Strom BL, Miettinen OS, Melmon KL. Postmarketing studies of drug efficacy: when must they be randomized? Clin Pharmacol Ther 1983; 34: 1–7.